MRI, Enhanced CT, and FDG PET/CT in Basal Cell Carcinoma of the Prostate

被引：1
|
作者：
Dong, Aisheng [1 ]
Zuo, Changjing [1 ]
Lu, Jianping [2 ]
Wang, Yang [3 ]
机构：
[1] Second Mil Med Univ, Changhai Hosp, Dept Nucl Med, Shanghai 200433, Peoples R China
[2] Second Mil Med Univ, Changhai Hosp, Dept Radiol, Shanghai 200433, Peoples R China
[3] Second Mil Med Univ, Changhai Hosp, Dept Pathol, Shanghai 200433, Peoples R China
来源：
CLINICAL NUCLEAR MEDICINE | 2014年 / 39卷 / 08期
关键词：
basal cell carcinoma; prostate cancer; prostate; MRI; CT; FDG; PET/CT;
D O I：
10.1097/RLU.0000000000000280
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Primary basal cell carcinoma of the prostate is a very rare neoplasm with a good prognosis. A 55-year-old man presented with urinary frequency for 2 months. Serum prostate-specific antigen level was normal. T2-weighted MR images showed an inhomogeneously hyperintense tumor in the prostate. Enhanced CT showed heterogeneous enhancement of the tumor. FDG PET/CT showed strong FDG uptake of the tumor with SUVmax of 14.1. Prostate biopsy findings revealed basal cell carcinoma with high proliferation index.
引用
收藏
页码：721 / 724
页数：4
相关论文
共 50 条
  • [21] The combination of FDG PET/CT and contrast enhanced CT in the evaluation of recurrent pancreatic carcinoma and cholangiocarcinoma
    Fardanesh, R. (mahmoudreza.fardanesh@mountsinai.org), 1600, Bentham Science Publishers (10):
  • [22] The Combination of FDG PET/CT and Contrast Enhanced CT in the Evaluation of Recurrent Pancreatic Carcinoma and Cholangiocarcinoma
    Peti, Steven
    Fardanesh, Reza
    Golan, Sivan
    Simpson, William
    Chin, Christopher
    Roayaie, Sasan
    Schwartz, Myron
    Labow, Daniel
    Kostakoglu, Lale
    CURRENT MEDICAL IMAGING REVIEWS, 2014, 10 (01) : 53 - 61
  • [23] Enhanced CT and FDG PET/CT in Histiocytic Sarcoma of the Pericardium
    Dong, Aisheng
    Wang, Yang
    Cui, Yong
    Zuo, Changjing
    CLINICAL NUCLEAR MEDICINE, 2016, 41 (04) : 326 - 327
  • [24] Enhanced CT and FDG PET/CT Findings of Splenic Hamartoma
    Dong, Aisheng
    Wang, Yang
    Lu, Jianping
    Zuo, Changjing
    CLINICAL NUCLEAR MEDICINE, 2014, 39 (11) : 968 - 971
  • [25] FDG PET/CT and incidental prostate avidity
    Franklin, Anthony
    Yaxley, John
    BJU INTERNATIONAL, 2022, 129 : 130 - 131
  • [26] FDG PET/CT Imaging of Prostate Carcinosarcoma
    Oldan, Jorge Daniel
    Chin, Bennett B.
    CLINICAL NUCLEAR MEDICINE, 2016, 41 (08) : 629 - 631
  • [27] Castleman Disease of the Porta Hepatis Mimicking Exophytic Hepatocellular Carcinoma on CT, MRI, and FDG PET/CT
    Dong, Aisheng
    Dong, Hui
    Zuo, Changjing
    CLINICAL NUCLEAR MEDICINE, 2014, 39 (01) : E69 - E72
  • [28] FDG-PET/contrast-enhanced CT as a post-treatment tool in head and neck squamous cell carcinoma: comparison with FDG-PET/non-contrast-enhanced CT and contrast-enhanced CT
    Suenaga, Yuko
    Kitajima, Kazuhiro
    Ishihara, Takeaki
    Sasaki, Ryohei
    Otsuki, Naoki
    Nibu, Ken-ichi
    Minamikawa, Tsutomu
    Kiyota, Naomi
    Sugimura, Kazuro
    EUROPEAN RADIOLOGY, 2016, 26 (04) : 1018 - 1030
  • [29] FDG-PET/contrast-enhanced CT as a post-treatment tool in head and neck squamous cell carcinoma: comparison with FDG-PET/non-contrast-enhanced CT and contrast-enhanced CT
    Yuko Suenaga
    Kazuhiro Kitajima
    Takeaki Ishihara
    Ryohei Sasaki
    Naoki Otsuki
    Ken-ichi Nibu
    Tsutomu Minamikawa
    Naomi Kiyota
    Kazuro Sugimura
    European Radiology, 2016, 26 : 1018 - 1030
  • [30] Advancement of PET and PET/CT in prostate carcinoma
    Reske, S. N.
    Blumstein, N. M.
    Glatting, G.
    UROLOGE, 2006, 45 (06): : 707 - +
12345